Exact Mass: 304.9583278
Exact Mass Matches: 304.9583278
Found 94 metabolites which its exact mass value is equals to given mass value 304.9583278,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Clioquinol
C9H5ClINO (304.91044200000005)
G - Genito urinary system and sex hormones > G01 - Gynecological antiinfectives and antiseptics > G01A - Antiinfectives and antiseptics, excl. combinations with corticosteroids > G01AC - Quinoline derivatives P - Antiparasitic products, insecticides and repellents > P01 - Antiprotozoals > P01A - Agents against amoebiasis and other protozoal diseases > P01AA - Hydroxyquinoline derivatives D - Dermatologicals > D08 - Antiseptics and disinfectants > D08A - Antiseptics and disinfectants > D08AH - Quinoline derivatives D - Dermatologicals > D09 - Medicated dressings > D09A - Medicated dressings > D09AA - Medicated dressings with antiinfectives S - Sensory organs > S02 - Otologicals > S02A - Antiinfectives > S02AA - Antiinfectives C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor C254 - Anti-Infective Agent
5-[(E)-(6-Bromo-1H-indole-3-yl)methylene]imidazolidine-2,4-dione
clioquinol
C9H5ClINO (304.91044200000005)
G - Genito urinary system and sex hormones > G01 - Gynecological antiinfectives and antiseptics > G01A - Antiinfectives and antiseptics, excl. combinations with corticosteroids > G01AC - Quinoline derivatives P - Antiparasitic products, insecticides and repellents > P01 - Antiprotozoals > P01A - Agents against amoebiasis and other protozoal diseases > P01AA - Hydroxyquinoline derivatives D - Dermatologicals > D08 - Antiseptics and disinfectants > D08A - Antiseptics and disinfectants > D08AH - Quinoline derivatives D - Dermatologicals > D09 - Medicated dressings > D09A - Medicated dressings > D09AA - Medicated dressings with antiinfectives S - Sensory organs > S02 - Otologicals > S02A - Antiinfectives > S02AA - Antiinfectives C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor C254 - Anti-Infective Agent
Acetamide,2,2,2-trichloro-N-[3-(trifluoromethyl)phenyl]-
C9H5Cl3F3NO (304.93888060000006)
Sodium risedronate
C78281 - Agent Affecting Musculoskeletal System > C67439 - Bone Resorption Inhibitor D050071 - Bone Density Conservation Agents > D004164 - Diphosphonates D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators
5-Chloro-2-methyl-3-(3-sulfopropyl)benzothiazolium,inner salt
2-Methyl-2-propanyl (2-bromo-4-chlorophenyl)carbamate
C11H13BrClNO2 (304.98181280000006)
5-(3-bromophenyl)thieno[2,3-d]pyrimidin-4-amine
C12H8BrN3S (304.96222680000005)
(4-bromophenyl)-(3-nitrophenyl)methanone
C13H8BrNO3 (304.96875180000006)
3-Ethyl-2-Methylbenzothiazolium Iodide
C10H12INS (304.97351820000006)
4-(2-PYRIDINYLOXY)BENZENESULFONYLCHLORIDEHYDROCHLORIDE
ETHYL 3-(5-BROMO-2-METHYL-4-NITRO-1H-IMIDAZOL-1-YL)PROPANOATE
C9H12BrN3O4 (305.00111319999996)
3-bromo-7-pyridin-3-ylthieno[3,2-c]pyridin-4-amine
C12H8BrN3S (304.96222680000005)
2-BROMO-3-CHLOROPHENYL N,N-DIETHYLCARBAMATE
C11H13BrClNO2 (304.98181280000006)
4-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazole-5-carbonyl chloride
6-bromo-3-chloro-N-(oxan-4-ylmethyl)pyrazin-2-amine
7-BROMO-1,2,3,4-TETRAHYDRO-ACRIDINE-9-CARBOXYLICACID
ETHYL 2-[(4,5-DICHLORO-1H-IMIDAZOL-1-YL)METHYL]-1,3-THIAZOLE-4-CARBOXYLATE
7-Chloro-5-iodo-8-hydroxyquinoline
C9H5ClINO (304.91044200000005)
ETHYL 2-CHLORO-2-(2-(4-CHLORO-2-NITROPHENYL)HYDRAZONO)ACETATE
C10H9Cl2N3O4 (304.99700939999997)
3-(6-Bromopyridin-2-yl)-4-methyl-benzoic acid methyl ester
4-Bromo-6-methoxy-2-(trifluoromethyl)quinoline
C11H7BrF3NO (304.96630680000004)
3-(2-Amino-4-pyrimidinyl)-6-bromo-1H-pyrrolo[2,3-b]pyridin-4-ol
tris(acetonitrile)tricarbonylmolybdenum
C9H9MoN3O3 (304.96979340000007)
4-(Pyridin-3-yloxy)benzene-1-sulfonyl chloride hydrochloride
5-(4-bromophenyl)thieno[2,3-d]pyrimidin-4-amine
C12H8BrN3S (304.96222680000005)
2-(5-BROMO-THIOPHEN-2-YL)-2,3-DIHYDRO-BENZOFURAN-5-CARBONITRILE
C13H8BrNOS (304.95099380000005)
6-Bromo-4-methoxy-2-(trifluoromethyl)quinoline
C11H7BrF3NO (304.96630680000004)
5-Bromo-2-(3-methyl-5-(trifluoromethyl)-1H-pyrazol-1-yl)pyridine
C10H7BrF3N3 (304.97753980000005)
2-Bromo-6-(3-methyl-5-(trifluoromethyl)-1H-pyrazol-1-yl)pyridine
C10H7BrF3N3 (304.97753980000005)
2-(2,6-DICHLOROBENZYL)THIAZOLE-4-CARBONYL CHLORIDE
C11H6Cl3NOS (304.92356760000007)
7-Nitro-9-oxo-9H-fluorene-2-sulfonic acid
C13H7NO6S (304.99940820000006)
Iodohippuric acid i-131
C1446 - Radiopharmaceutical Compound > C2124 - Radioconjugate
2-(2,3,3-Trichloro-1-nitroprop-2-enylidene)-1,3-dihydrobenzimidazole
C10H6Cl3N3O2 (304.95255860000003)
alpha-D-ribose 1-methylphosphonate 5-phosphate(3-)
2-(5-Bromo-2-furanyl)-6-methyl-3,1-benzoxazin-4-one
C13H8BrNO3 (304.96875180000006)
5-chloro-7-iodoquinolin-8-ol
C9H5ClINO (304.91044200000005)
A monohydroxyquinoline that is quinolin-8-ol in which the hydrogens at positions 5 and 7 are replaced by chlorine and iodine, respectively. It has antibacterial and atifungal properties, and is used in creams for the treatment of skin infections. It has also been investigated as a chelator of copper and zinc ions for the possible treatment of Alzheimers disease.
Taminadenant
Taminadenant (NIR178; PBF509) is a highly potent and orally active adenosine A2A receptor (A2AR) antagonist. Taminadenant can antagonize A2AR agonist-mediated cAMP accumulation and impedance responses with KB values of 72.8 nM and 8.2 nM, respectively. Taminadenant reverses motor impairments in several rat models of movement disorders, including catalepsy, tremor, and hemiparkinsonism. Taminadenant can also inhibit tumor growth when combined with Spartalizumab (HY-P9972). Taminadenant reactivate the antitumor immune response[1][2].